Where does Phylos Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Phylos Bioscience, Inc. ranks #36,970 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Phylos Bioscience, Inc. hold?

Phylos Bioscience, Inc. holds 7 US utility patents granted between 2022 and 2025, spanning 4 technology areas.

What is Phylos Bioscience, Inc.'s Innovation Score?

Phylos Bioscience, Inc. has an Innovation Score of 39.1 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Phylos Bioscience, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Phylos Bioscience, Inc..

What does claim depth mean for Phylos Bioscience, Inc.'s patents?

Phylos Bioscience, Inc.'s patents average 8.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Phylos Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Phylos Bioscience, Inc.

Q: What technology areas does Phylos Bioscience, Inc. focus on?

Phylos Bioscience, Inc.'s top technology area is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques) with 3 patents, ranking #140 of 285 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Phylos ranks #36,970 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#36,970
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.1/100): 8.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R36970 · US Corporation #36,970 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #36,970/49,997
PHOTO-FINISH Phoenix Children's…
CPC-NARROW A01H · 4 areas
INNOV-THIN 39.1/100
CLAIMS-PAR 8.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Phoenix Children's Hospital, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Phylos’s 39.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (18%) Velocity 20.0 pts (51%) Breadth 7.1 pts (18%) Claim depth 4.9 pts (13%)

Qualcomm Incorporated · highest

85
Phylos Bioscience · this assignee

39
3D Lighting… · lowest

7

What this shows Phylos's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Phylos?

Each dot is one of Phylos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Phylos’s own 8.1 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Phylos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Phylos's grants concentrate

Phylos Bioscience, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 42.9% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2022. By volume, Phylos sits between Phoenix Children's Hospital, Inc. and PicoCELA Inc..

Phylos's three-year grant acceleration

Phylos Bioscience, Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Phoenix Children'…

7
Phokus Research G…

7
Photo U

7
Photoneo s r o

7
Physical Systems

7
Physmodo

7
Phyzhon Health

7
Picocela

7
Phylos Bioscience ◀

7

What this shows Phylos holds 7 patents at rank #37,011, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Phylos

By rank, the assignees closest to #37,011 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in Phylos's primary technology class.

Phylos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Phylos Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	14.3%
2023	1	14.3%
2024	2	28.6%
2025partial year	3	42.9%

Which technologies does Phylos Bioscience, Inc. patent most?

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07K - Peptides 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Phylos Bioscience, Inc.'s patent record in context - here's where to go next.

Phylos Bioscience, Inc.'s lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 42.9% of its portfolio - see every assignee active in that class. Explore A01H
Ranked #36,970 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Phylos Bioscience, Inc. against Phoenix Children's Hospital, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.